PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Dec-2022 Hormonal Contraceptives Market surpassed US$ 16.3 Bn in 2021 and is projected to accelerate at a CAGR of 4.3% from 2023 to 2032 | insightSLICE insightSLICE
01-Dec-2022 Electrophysiology Devices Market to achieve CAGR of 11.1% from 2023 to 2032, owing to the rising prevalence of cardiac arrhythmia | insightSLICE insightSLICE
01-Dec-2022 Cataract Surgical Devices Market surpassed US$ 7.95 billion in 2021 | insightSLICE insightSLICE
01-Dec-2022 Global Analytical Laboratory Services Market Report 2022: Favorable Government Policies to Strengthen Analytical Testing Capabilities Driving Growth - ResearchAndMarkets.com Businesswire
01-Dec-2022 Upgrading to FFP3 face masks in hospitals could save the NHS £360m a year and help slash patient waiting lists Globus Group
01-Dec-2022 SpectrumX’s Hand Sanitiser Approved for NHS Supply Chain’s NHS Supplier List Businesswire
01-Dec-2022 AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases Businesswire
01-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Dec-2022 ViiV Healthcare unveils a new global study revealing three quarters of people believe there are still negative perceptions when it comes to people living with HIV ViiV Healthcare
01-Dec-2022 Nass Valley Gardens Announces It Has Contracted Its Reg A+ Capital Raise Team Nass Valley Gateway Ltd.
01-Dec-2022 Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups Andrew Lloyd Associates
01-Dec-2022 Adocia Strengthens Its Cash Position with EUR 6 Million Through the Issuance of Convertible Bonds Subscribed by European Investors in Order to Accelerate the Development of Key Products Businesswire
01-Dec-2022 Change in the Management of CHEPLAPHARM Cheplapharm AG
01-Dec-2022 Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology Avectas
01-Dec-2022 RetinAI launches Discovery CORE™: an AI-powered, collaborative platform to accelerate Clinical and Academic Research, and RWE analysis in ophthalmology RetinAI
01-Dec-2022 Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process Creative Proteomics
01-Dec-2022 Creative Proteomics Lipidomics Launches Ceramides Analysis Service Creative Proteomics
01-Dec-2022 Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service Creative Proteomics
01-Dec-2022 BRIM Biotechnology, Inc. raises $20 million in Series E funding round Sciad Newswire
01-Dec-2022 BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT Biophytis